EYES News and Press, Second Sight Medical Products Inc. From 07/02/21

Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar for companies due to report. Mond...

These Current & Former Biotech Penny Stocks Have Seen A Strong Year So Far One of the great things about biotech penny stocks is the potential of these companies. There are very few places that offer this kind of early access to potentially life-saving treatments. If you take a ...

Second Sight Medical Products ([[EYES]] -2.1%) said underwriters of its previously announced public offering exercised their option in full to buy an additional 1.5M common shares at $5 apiece for $7.5M.In total the company sold 11.5M shares for gross proceeds of about $57.5M.Second Sigh...

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the closing of i...

Gainers: Entera Bio (ENTX) +56%. Orphazyme (ORPH) +47%. Bellerophon Therapeutics (BLPH) +26%. HUTCHMED (HCM) +11%. Evaxion Biotech (EVAX) +8%.Losers: Gemini Therapeutics (GMTX) -32%. Second Sight Medical Products (EYES) -19%. Millendo Therapeutics (MLND) -17...

Gemini Therapeutics (GMTX) -31% after initial data from mid-stage GEM103 AMD study.Second Sight Medical Products (EYES) -18% after secures $50M capital via equity raiseTorchlight Energy Resources (TRCH) -17%.Alfi (ALF) -16% stock pulls back from buyback-fueled ra...

Mark_Kuiken/iStock via Getty Images Second Sight Medical Products (EYES) has priced its public offering of 10M common shares at $5.00/share, for gross proceeds of $50M. Underwriters' over-allotment is an additional 1.5M shares. Net proceeds will be used for for development of the Orion device...

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced the pricing of i...

Second Sight Medical Products (EYES) announces that the company intends to offer to sell shares in an underwritten public offering.The financial terms of the offering were not disclosed.Intends to use net proceeds from the offering primarily for development of the Orion device and genera...

Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”) a leading developer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today announced that it intends t...